glp 1 for chronic kidney disease GLP-1 agonists in the treatment of in type 2 diabetes and obesity Glucagon-Like Peptide-1 Receptor Agonist Use

Read More HR Consulting Optimize your workforce with expert HR advisory, organizational development, policy creation, and compliance support

The question is who pays, how much, and through what mechanism

Tinsley, G

Add employer caps and BMI cutoffs, and millions of Americans now have zero GLP-1 coverage for obesity, with the rest becoming more fenced behind complex prior-authorization mazes

Mounjaro is designed for once-weekly dosing, and tirzepatide has a half-life of about 5 days, which is what supports the weekly schedule

In other top trends, 38% of panel members listed wearable technology with AI among their top two trends, and 38% listed food as medicine among their top two trends